Member Info for doggo

Back to booster boy to carry on knocking…

Prague is now planning full legalization for 2023 and wants to coordinate in lockstep with Berlin.

Lame

All the US pot stocks having an excellent start for what looks a down day across the pond.

5 US States vote for legalisation on Tuesday which would give the magic 50%+

Congress to vote through SAFE in lake duck season and it’s game on.

The weekly I’ve been in private equity for 30 years man and boy post.

The discount to NAV has never been larger

The NAV is 3x the SP

I think I can get the sheep to post at least 30 tonight..

Had your booster yet mIdas?

No jabs for me Midas. How are you doing? I remember you and a few of the gang in here excitedly telling us you had the jab…lol

It’s tough when you are so skint that you need to sacrifice your kids education and go for in-term all-inclusive drink all you can holidays to Spain..

Advice- keep them in school and go to the seaside.

Chav.

You are possibly the most boring person you know Midas. The wife and kids must be so glad you are still working at your age after all your success in the private equity space.

I’d read the LGP Q3 report Longlad before opening your mouth. Will give obvious reasons why they are raising now…https://investor.littlegreenpharma.com/site/investor-centre/asx-announcements?Archive=True&ArchiveMonth=9&ArchiveQuarter=Q3&Archive6Mths=H2&ArchiveYear=2020&FilterStyle=B&year=2022&month=&DisplayType=E&Page=5

I was surprised that these were not in an RNS on Monday by the way Ed if you are looking in..

All the residents of the seed asylum appear happy and comforted.

Yes

Expect Yooma wellness to delist at any time.
Phoenix emerges
Up to 3 companies to take the assets

Yooma Europe (they own all the recent European acquisitions) possibly rebrand to The Wellness Group)
Vitality CBD (largest asset by brand size)
Novel Drinks Europe (Socati IP)

We might be in for a decent return

Excellent news

Congress is getting “very close” to introducing and passing a marijuana bill with provisions covering banking access for legal businesses.

The Company continues to invest in research and development associated with supplying the French Trial which is scheduled for completion in March 2023. Post completion of the Trial LGP is ideally positioned to capitalise on their significant brand equity and first mover advantage in the French Market.

LGP has invested to build a dominant EU distribution platform and now has supply arrangements or investments in 10 jurisdictions, one of the largest EU GMP production facilities in Europe, a world class genetics database, and market access to over 76% of EU and UK citizens.

European sales contracts with minimum commitments: Subject to these European supply arrangements satisfying their conditions precedent and LGP’s partners meeting their minimum purchase commitments, these existing transactions have a combined potential value of $45.4 million1 in revenue over the next three years.

The Company continues to execute its strategy of developing bespoke, high-value white label strains for export to Europe, with the Company signing a key supply agreement with Cannamedical Pharma GmbH (“Cannamedical”)2 in October for ~$4.5 million (€3 million)3 over two years. As indicated in the European sales pipeline diagram on page 4, this agreement represents LGP’s fourth key contract for the supply of medicinal cannabis into Germany and gives LGP access to three of the four largest independent, own-branded medicinal cannabis distributors in the largest market in Europe.

Subsequent to the award of the Italian tender in February5, the Company and the Italian Government agreed to supply an additional €100,000 of cannabis flower in Q4CY2022 under the tender terms, bringing the total value of the award to $465,000 (€300,000).
In addition, the Company has also submitted a bid in connection with a further tender by the Italian Government valued at $2.5 million (€1.6 million), of which LGP is one of only two bidders. Italian Government flower tenders impose some of the highest GMP product quality standards globally, with LGP being one of only two suppliers to have previously been awarded a tender. The results are expected to be announced mid-November.

With the German government in the early stages of legalising cannabis and LGP having 4 German supply contracts plus supplying French government trials and awaiting Italian Government tender news this month (into final 2) a huge chunk of the LGP raise will be magnificent news for Ed.